Market Overview:
The global heart stent market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in stent technology, and rising demand for minimally invasive procedures. The drug-eluting stent segment is expected to dominate the global heart stent market during the forecast period. This segment is projected to grow at a CAGR of 5.8% from 2018 to 2030 owing to its advantages over other types of stents such as lower rates of restenosis and thrombosis formation. In terms of application, the acute myocardial infarction segment is expected to account for the largest share of the global heart stent market during the forecast period.
Product Definition:
A heart stent is a tiny mesh tube that's inserted into an artery to prop it open and improve blood flow. It's often used to treat coronary artery disease, a condition in which the arteries that supply blood to the heart become narrowed or blocked.
Drug-Eluting Stent:
A drug-eluting stent is a medical device used to treat coronary artery disease. The device consists of a metal or polymer frame that is inserted into the arteries and the body tissue around it, which helps in reducing the damage to blood vessels. It also prevents reoccurrence of coronary heart diseases (CHD). Rising prevalence of Coronary Artery Disease (CAD) globally has led to an increase in demand for these devices, thereby driving their growth over the forecast period.
Bare Metal Stent:
Bare metal stent is a kind of medical device used to clear blockages in blood vessels. It is a thin, hollow tube made from fine wire and can be used for angioplasty (balloon angioplasty) or coronary artery disease treatment.
Application Insights:
The acute myocardial infarction segment held the largest market share in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to increasing incidence of AMI coupled with rising awareness among individuals regarding early treatment. According to a study published in 2018 by NCBI, out of every 1000 deaths caused by AMI, about 250 occur in people who have symptoms but not yet been diagnosed. Thus, increasing incidence coupled with rising awareness is expected to drive demand for coronary stents during the forecast period.
Unstable angina pectoris application segment is anticipated register a significant CAGR during the forecast period owing to growing prevalence of this condition and availability of advanced devices that help ease pain without limitations imposed by other medications or invasive procedures such as bypass surgery.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing healthcare expenditure, and rising incidence of AMI. Moreover, growing target population base with a high risk of developing cardiovascular diseases is expected to drive the regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare infrastructure and economic development in emerging countries such as India and China. In addition, increasing patient awareness levels regarding advanced heart stents are expected to fuel regional demand during the forecast period. However, stringent regulatory guidelines pertaining political reasons may hinder market growth over projected time frame (8 years).
Growth Factors:
- Increasing incidence of heart diseases: The increasing incidence of heart diseases is one of the key growth drivers for the global heart stent market. According to a study by the World Health Organization (WHO), an estimated 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. This number is expected to increase to 23 million by 2030. This growing prevalence of heart diseases is expected to drive demand for heart stents in the coming years.
- Technological advancements: The technological advancements in the field of cardiac surgery are another key growth driver for the global heart stent market. With continuous innovations and developments, new and advanced types of stents are being introduced in the market, which are helping surgeons treat complex cardiac conditions more effectively and safely than ever before. This is likely to boost demand for these devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Heart Stent Market Research Report
By Type
Drug-Eluting Stent, Bare Metal Stent, Bioactive Stent, Radioactive Stent
By Application
Acute Myocardial Infarction, Unstable Angina, Angina Pectoris
By Companies
Abbott, Medtronic, Boston Scientific, Biosensor International, Terumo, MicroPort Scientific, Lepu Medical, B.Braun, HEXACATH, Biotronik AG, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Heart Stent Market Report Segments:
The global Heart Stent market is segmented on the basis of:
Types
Drug-Eluting Stent, Bare Metal Stent, Bioactive Stent, Radioactive Stent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute Myocardial Infarction, Unstable Angina, Angina Pectoris
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Medtronic
- Boston Scientific
- Biosensor International
- Terumo
- MicroPort Scientific
- Lepu Medical
- B.Braun
- HEXACATH
- Biotronik AG
- Abbott
Highlights of The Heart Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug-Eluting Stent
- Bare Metal Stent
- Bioactive Stent
- Radioactive Stent
- By Application:
- Acute Myocardial Infarction
- Unstable Angina
- Angina Pectoris
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heart Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A heart stent is a small, metal tube that is inserted into the coronary artery to keep it open. This allows blood to flow more easily through the artery and prevents a heart attack or stroke.
Some of the key players operating in the heart stent market are Abbott, Medtronic, Boston Scientific, Biosensor International, Terumo, MicroPort Scientific, Lepu Medical, B.Braun, HEXACATH, Biotronik AG, Abbott.
The heart stent market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Heart Stent Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Heart Stent Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Heart Stent Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Heart Stent Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Heart Stent Market Size & Forecast, 2020-2028 4.5.1 Heart Stent Market Size and Y-o-Y Growth 4.5.2 Heart Stent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Drug-Eluting Stent
5.2.2 Bare Metal Stent
5.2.3 Bioactive Stent
5.2.4 Radioactive Stent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Acute Myocardial Infarction
6.2.2 Unstable Angina
6.2.3 Angina Pectoris
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Heart Stent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Heart Stent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Drug-Eluting Stent
9.6.2 Bare Metal Stent
9.6.3 Bioactive Stent
9.6.4 Radioactive Stent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Acute Myocardial Infarction
9.10.2 Unstable Angina
9.10.3 Angina Pectoris
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Drug-Eluting Stent
10.6.2 Bare Metal Stent
10.6.3 Bioactive Stent
10.6.4 Radioactive Stent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Acute Myocardial Infarction
10.10.2 Unstable Angina
10.10.3 Angina Pectoris
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Drug-Eluting Stent
11.6.2 Bare Metal Stent
11.6.3 Bioactive Stent
11.6.4 Radioactive Stent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Acute Myocardial Infarction
11.10.2 Unstable Angina
11.10.3 Angina Pectoris
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Drug-Eluting Stent
12.6.2 Bare Metal Stent
12.6.3 Bioactive Stent
12.6.4 Radioactive Stent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Acute Myocardial Infarction
12.10.2 Unstable Angina
12.10.3 Angina Pectoris
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Drug-Eluting Stent
13.6.2 Bare Metal Stent
13.6.3 Bioactive Stent
13.6.4 Radioactive Stent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Acute Myocardial Infarction
13.10.2 Unstable Angina
13.10.3 Angina Pectoris
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Heart Stent Market: Competitive Dashboard
14.2 Global Heart Stent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Medtronic
14.3.3 Boston Scientific
14.3.4 Biosensor International
14.3.5 Terumo
14.3.6 MicroPort Scientific
14.3.7 Lepu Medical
14.3.8 B.Braun
14.3.9 HEXACATH
14.3.10 Biotronik AG
14.3.11 Abbott